世界の大腿静脈カニューレ市場2020年:製造業者別、地域別、種類・用途別

【英語タイトル】Global Femoral Venous Cannulae Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP11306)・商品コード:GIR20SP11306
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月25日(※2024年版があります。お問い合わせください)
・ページ数:105
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、大腿静脈カニューレの世界市場を広く調査・分析し、今後の市場展望をまとめております。大腿静脈カニューレの種類別市場規模(単段、二段)、用途別市場規模(病院、外来手術センター(ASC)、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Medtronic、Surge Cardiovascular、Edward Lifescience、LivaNova、KangXin Medical
・地域別グローバル市場分析 2015年-2020年
・大腿静脈カニューレの北米市場(アメリカ、カナダ、メキシコ)
・大腿静脈カニューレのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・大腿静脈カニューレのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・大腿静脈カニューレの南米市場(ブラジル、アルゼンチン)
・大腿静脈カニューレの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:単段、二段
・用途別分析:病院、外来手術センター(ASC)、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Femoral Venous Cannulae market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Femoral Venous Cannulae sales will be xx in 2020 from Femoral Venous Cannulae million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Femoral Venous Cannulae market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Femoral Venous Cannulae industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Femoral Venous Cannulae and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Femoral Venous Cannulae market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Femoral Venous Cannulae market has been segmented into
Single-stage
Two-stage

By Application, Femoral Venous Cannulae has been segmented into:
Hospitals
Ambulatory Surgical Centers (ASC)
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Femoral Venous Cannulae market presented in the report. This section sheds light on the sales growth of different regional and country-level Femoral Venous Cannulae markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Femoral Venous Cannulae market.

The report offers in-depth assessment of the growth and other aspects of the Femoral Venous Cannulae market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Femoral Venous Cannulae Market Share Analysis
Femoral Venous Cannulae competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Femoral Venous Cannulae sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Femoral Venous Cannulae sales, revenue and market share for each player covered in this report.

The major players covered in Femoral Venous Cannulae are:
Medtronic
Surge Cardiovascular
Edward Lifescience
LivaNova
KangXin Medical

Among other players domestic and global, Femoral Venous Cannulae market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Femoral Venous Cannulae product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Femoral Venous Cannulae, with price, sales, revenue and global market share of Femoral Venous Cannulae in 2018 and 2019.
Chapter 3, the Femoral Venous Cannulae competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Femoral Venous Cannulae breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Femoral Venous Cannulae market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Femoral Venous Cannulae sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Femoral Venous Cannulae Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Femoral Venous Cannulae Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Single-stage
1.2.3 Two-stage
1.3 Market Analysis by Application
1.3.1 Overview: Global Femoral Venous Cannulae Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers (ASC)
1.3.4 Others
1.4 Overview of Global Femoral Venous Cannulae Market
1.4.1 Global Femoral Venous Cannulae Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Femoral Venous Cannulae Industry Impact
1.6.1 COVID-19 Potential Implications for the Femoral Venous Cannulae
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Femoral Venous Cannulae
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Surge Cardiovascular
2.2.1 Surge Cardiovascular Details
2.2.2 Surge Cardiovascular Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Surge Cardiovascular SWOT Analysis
2.2.4 Surge Cardiovascular Product and Services
2.2.5 Surge Cardiovascular Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Edward Lifescience
2.3.1 Edward Lifescience Details
2.3.2 Edward Lifescience Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Edward Lifescience SWOT Analysis
2.3.4 Edward Lifescience Product and Services
2.3.5 Edward Lifescience Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 LivaNova
2.4.1 LivaNova Details
2.4.2 LivaNova Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 LivaNova SWOT Analysis
2.4.4 LivaNova Product and Services
2.4.5 LivaNova Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 KangXin Medical
2.5.1 KangXin Medical Details
2.5.2 KangXin Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 KangXin Medical SWOT Analysis
2.5.4 KangXin Medical Product and Services
2.5.5 KangXin Medical Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Femoral Venous Cannulae Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Femoral Venous Cannulae Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Femoral Venous Cannulae Manufacturer Market Share in 2019
3.3.2 Top 6 Femoral Venous Cannulae Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Femoral Venous Cannulae Sales, Revenue and Market Share by Regions
4.1.1 Global Femoral Venous Cannulae Sales and Market Share by Regions (2015-2020)
4.1.2 Global Femoral Venous Cannulae Revenue and Market Share by Regions (2015-2020)
4.2 North America Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
4.3 Europe Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
4.5 South America Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Femoral Venous Cannulae Sales, Revenue and Market Share by Country
5.1.1 North America Femoral Venous Cannulae Sales and Market Share by Country (2015-2020)
5.1.2 North America Femoral Venous Cannulae Revenue and Market Share by Country (2015-2020)
5.2 United States Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
5.3 Canada Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
5.4 Mexico Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Femoral Venous Cannulae Sales, Revenue and Market Share by Country
6.1.1 Europe Femoral Venous Cannulae Sales and Market Share by Country (2015-2020)
6.1.2 Europe Femoral Venous Cannulae Revenue and Market Share by Country (2015-2020)
6.2 Germany Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
6.3 UK Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
6.4 France Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
6.5 Russia Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
6.6 Italy Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Femoral Venous Cannulae Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Femoral Venous Cannulae Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Femoral Venous Cannulae Revenue and Market Share by Regions (2015-2020)
7.2 China Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
7.3 Japan Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
7.4 Korea Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
7.5 India Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
7.7 Australia Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Femoral Venous Cannulae Sales, Revenue and Market Share by Country
8.1.1 South America Femoral Venous Cannulae Sales and Market Share by Country (2015-2020)
8.1.2 South America Femoral Venous Cannulae Revenue and Market Share by Country (2015-2020)
8.2 Brazil Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
8.3 Argentina Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Femoral Venous Cannulae Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Femoral Venous Cannulae Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Femoral Venous Cannulae Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
9.3 Turkey Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
9.4 Egypt Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
9.5 South Africa Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Femoral Venous Cannulae Sales and Market Share by Type (2015-2020)
10.2 Global Femoral Venous Cannulae Revenue and Market Share by Type (2015-2020)
10.3 Global Femoral Venous Cannulae Price by Type (2015-2020)
11 Global Femoral Venous Cannulae Market Segment by Application
11.1 Global Femoral Venous Cannulae Sales Market Share by Application (2015-2020)
11.2 Global Femoral Venous Cannulae Revenue Market Share by Application (2015-2020)
11.3 Global Femoral Venous Cannulae Price by Application (2015-2020)
12 Market Forecast
12.1 Global Femoral Venous Cannulae Sales, Revenue and Growth Rate (2021-2025)
12.2 Femoral Venous Cannulae Market Forecast by Regions (2021-2025)
12.2.1 North America Femoral Venous Cannulae Market Forecast (2021-2025)
12.2.2 Europe Femoral Venous Cannulae Market Forecast (2021-2025)
12.2.3 Asia-Pacific Femoral Venous Cannulae Market Forecast (2021-2025)
12.2.4 South America Femoral Venous Cannulae Market Forecast (2021-2025)
12.2.5 Middle East & Africa Femoral Venous Cannulae Market Forecast (2021-2025)
12.3 Femoral Venous Cannulae Market Forecast by Type (2021-2025)
12.3.1 Global Femoral Venous Cannulae Sales Forecast by Type (2021-2025)
12.3.2 Global Femoral Venous Cannulae Market Share Forecast by Type (2021-2025)
12.4 Femoral Venous Cannulae Market Forecast by Application (2021-2025)
12.4.1 Global Femoral Venous Cannulae Sales Forecast by Application (2021-2025)
12.4.2 Global Femoral Venous Cannulae Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Femoral Venous Cannulae Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Femoral Venous Cannulae by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Femoral Venous Cannulae Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Femoral Venous Cannulae Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Medtronic Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Femoral Venous Cannulae Major Business
Table 10. Medtronic Femoral Venous Cannulae Total Revenue (USD Million) (2018-2019)
Table 11. Medtronic SWOT Analysis
Table 12. Medtronic Femoral Venous Cannulae Product and Services
Table 13. Medtronic Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Surge Cardiovascular Basic Information, Manufacturing Base and Competitors
Table 15. Surge Cardiovascular Femoral Venous Cannulae Major Business
Table 16. Surge Cardiovascular Femoral Venous Cannulae Total Revenue (USD Million) (2018-2019)
Table 17. Surge Cardiovascular SWOT Analysis
Table 18. Surge Cardiovascular Femoral Venous Cannulae Product and Services
Table 19. Surge Cardiovascular Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Edward Lifescience Basic Information, Manufacturing Base and Competitors
Table 21. Edward Lifescience Femoral Venous Cannulae Major Business
Table 22. Edward Lifescience Femoral Venous Cannulae Total Revenue (USD Million) (2018-2019)
Table 23. Edward Lifescience SWOT Analysis
Table 24. Edward Lifescience Femoral Venous Cannulae Product and Services
Table 25. Edward Lifescience Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. LivaNova Basic Information, Manufacturing Base and Competitors
Table 27. LivaNova Femoral Venous Cannulae Major Business
Table 28. LivaNova Femoral Venous Cannulae Total Revenue (USD Million) (2018-2019)
Table 29. LivaNova SWOT Analysis
Table 30. LivaNova Femoral Venous Cannulae Product and Services
Table 31. LivaNova Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. KangXin Medical Basic Information, Manufacturing Base and Competitors
Table 33. KangXin Medical Femoral Venous Cannulae Major Business
Table 34. KangXin Medical Femoral Venous Cannulae Total Revenue (USD Million) (2018-2019)
Table 35. KangXin Medical SWOT Analysis
Table 36. KangXin Medical Femoral Venous Cannulae Product and Services
Table 37. KangXin Medical Femoral Venous Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Global Femoral Venous Cannulae Sales by Manufacturer (2018-2019) (K Units)
Table 39. Global Femoral Venous Cannulae Revenue by Manufacturer (2018-2019) (USD Million)
Table 40. Global Femoral Venous Cannulae Sales by Regions (2015-2020) (K Units)
Table 41. Global Femoral Venous Cannulae Sales Market Share by Regions (2015-2020)
Table 42. Global Femoral Venous Cannulae Revenue by Regions (2015-2020) (USD Million)
Table 43. North America Femoral Venous Cannulae Sales by Countries (2015-2020) (K Units)
Table 44. North America Femoral Venous Cannulae Sales Market Share by Countries (2015-2020)
Table 45. North America Femoral Venous Cannulae Revenue by Countries (2015-2020) (USD Million)
Table 46. North America Femoral Venous Cannulae Revenue Market Share by Countries (2015-2020)
Table 47. Europe Femoral Venous Cannulae Sales by Countries (2015-2020) (K Units)
Table 48. Europe Femoral Venous Cannulae Sales Market Share by Countries (2015-2020)
Table 49. Europe Femoral Venous Cannulae Revenue by Countries (2015-2020) (USD Million)
Table 50. Asia-Pacific Femoral Venous Cannulae Sales by Regions (2015-2020) (K Units)
Table 51. Asia-Pacific Femoral Venous Cannulae Sales Market Share by Regions (2015-2020)
Table 52. Asia-Pacific Femoral Venous Cannulae Revenue by Regions (2015-2020) (USD Million)
Table 53. South America Femoral Venous Cannulae Sales by Countries (2015-2020) (K Units)
Table 54. South America Femoral Venous Cannulae Sales Market Share by Countries (2015-2020)
Table 55. South America Femoral Venous Cannulae Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Femoral Venous Cannulae Revenue Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Femoral Venous Cannulae Sales by Countries (2015-2020) (K Units)
Table 58. Middle East & Africa Femoral Venous Cannulae Sales Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Femoral Venous Cannulae Revenue by Countries (2015-2020) (USD Million)
Table 60. Middle East & Africa Femoral Venous Cannulae Revenue Market Share by Countries (2015-2020)
Table 61. Global Femoral Venous Cannulae Sales by Type (2015-2020) (K Units)
Table 62. Global Femoral Venous Cannulae Sales Share by Type (2015-2020)
Table 63. Global Femoral Venous Cannulae Revenue by Type (2015-2020) (USD Million)
Table 64. Global Femoral Venous Cannulae Revenue Share by Type (2015-2020)
Table 65. Global Femoral Venous Cannulae Sales by Application (2015-2020) (K Units)
Table 66. Global Femoral Venous Cannulae Sales Share by Application (2015-2020)
Table 67. Global Femoral Venous Cannulae Sales Forecast by Regions (2021-2025) (K Units)
Table 68. Global Femoral Venous Cannulae Market Share Forecast by Regions (2021-2025)
Table 69. Global Femoral Venous Cannulae Sales Forecast by Type (2021-2025) (K Units)
Table 70. Global Femoral Venous Cannulae Market Share Forecast by Type (2021-2025)
Table 71. Global Femoral Venous Cannulae Sales Forecast by Application (2021-2025)
Table 72. Global Femoral Venous Cannulae Market Share Forecast by Application (2021-2025)
Table 73. Direct Channel Pros & Cons
Table 74. Indirect Channel Pros & Cons
Table 75. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Femoral Venous Cannulae Picture
Figure 2. Global Sales Market Share of Femoral Venous Cannulae by Type in 2019
Figure 3. Single-stage Picture
Figure 4. Two-stage Picture
Figure 5. Femoral Venous Cannulae Sales Market Share by Application in 2018
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers (ASC) Picture
Figure 8. Others Picture
Figure 9. Global Femoral Venous Cannulae Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Femoral Venous Cannulae Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Femoral Venous Cannulae Sales Market Share by Manufacturer in 2019
Figure 30. Global Femoral Venous Cannulae Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Femoral Venous Cannulae Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Femoral Venous Cannulae Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Femoral Venous Cannulae Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Femoral Venous Cannulae Revenue Market Share by Regions (2015-2020)
Figure 37. Global Femoral Venous Cannulae Revenue Market Share by Regions in 2018
Figure 38. North America Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
Figure 39. Europe Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
Figure 41. South America Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Femoral Venous Cannulae Sales and Growth Rate (2015-2020)
Figure 43. North America Femoral Venous Cannulae Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Femoral Venous Cannulae Sales Market Share by Countries (2015-2020)
Figure 45. North America Femoral Venous Cannulae Sales Market Share by Countries in 2018
Figure 46. North America Femoral Venous Cannulae Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Femoral Venous Cannulae Revenue Market Share by Countries in 2018
Figure 48. United States Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Femoral Venous Cannulae Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Femoral Venous Cannulae Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Femoral Venous Cannulae Revenue Market Share by Countries in 2019
Figure 54. Germany Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Femoral Venous Cannulae Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Femoral Venous Cannulae Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Femoral Venous Cannulae Revenue Market Share by Regions 2019
Figure 62. China Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Femoral Venous Cannulae Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Femoral Venous Cannulae Sales Market Share by Countries in 2019
Figure 69. South America Femoral Venous Cannulae Revenue Market Share by Countries in 2019
Figure 70. Brazil Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Femoral Venous Cannulae Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Femoral Venous Cannulae Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Femoral Venous Cannulae Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Femoral Venous Cannulae Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Femoral Venous Cannulae Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Femoral Venous Cannulae Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Femoral Venous Cannulae Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Femoral Venous Cannulae Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Femoral Venous Cannulae Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Femoral Venous Cannulae Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Femoral Venous Cannulae Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Femoral Venous Cannulae Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Medtronic、Surge Cardiovascular、Edward Lifescience、LivaNova、KangXin Medical

★調査レポート[世界の大腿静脈カニューレ市場2020年:製造業者別、地域別、種類・用途別] (コード:GIR20SP11306)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の大腿静脈カニューレ市場2020年:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆